Findings in breast tomosynthesis screening – What do they look like?
- 8 September 2022
- journal article
- editorial
- Published by Elsevier in European Journal of Radiology
- Vol. 156, 110508
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Digital Mammography versus Digital Mammography Plus Tomosynthesis in Breast Cancer Screening: The Oslo Tomosynthesis Screening TrialRadiology, 2019
- Interval breast cancers in the ‘screening with tomosynthesis or standard mammography’ (STORM) population-based trialThe Breast, 2018
- Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening TrialBreast Cancer Research and Treatment, 2018
- Breast cancer screening with tomosynthesis (3D mammography) with acquired or synthetic 2D mammography compared with 2D mammography alone (STORM-2): a population-based prospective studyThe Lancet Oncology, 2016
- False positives in breast cancer screening with one-view breast tomosynthesis: An analysis of findings leading to recall, work-up and biopsy rates in the Malmö Breast Tomosynthesis Screening TrialEuropean Radiology, 2016
- Risk of breast cancer after false‐positive results in mammographic screeningCancer Medicine, 2016
- Do mammographic tumor features in breast cancer relate to breast density and invasiveness, tumor size, and axillary lymph node involvement?Acta Radiologica, 2015
- Comparison of Digital Mammography Alone and Digital Mammography Plus Tomosynthesis in a Population-based Screening ProgramRadiology, 2013
- Association of Stellate Mammographic Pattern with Survival in Small Invasive Breast TumorsAmerican Journal of Roentgenology, 2006
- Mammographic tumor features can predict long‐term outcomes reliably in women with 1–14‐mm invasive breast carcinomaCancer, 2004